Cited by 94Retinal Diseases and TreatmentsRetinal Development and DisordersRetinal Imaging and Analysis

Genetics of age-related macular degeneration: current concepts, future directions

Open access
DeAngelis, Margaret M., Silveira, Alexandra C., Carr, Elizabeth A., Kim, Ivana K.·2011·Seminars in Ophthalmology

Abstract

Age-related macular degeneration (AMD) is a progressive degenerative disease which leads to blindness, affecting the quality of life of millions of Americans. More than 1.75 million individuals in the United States are affected by the advanced form of AMD. The etiological pathway of AMD is not yet fully understood, but there is a clear genetic influence on disease risk. To date, the 1q32 (CFH) and 10q26 (PLEKHA1/ARMS2/HTRA1) loci are the most strongly associated with disease; however, the variation in these genomic regions alone is unable to predict disease development with high accuracy. Therefore, current genetic studies are aimed at identifying new genes associated with AMD and their modifiers, with the goal of discovering diagnostic or prognostic biomarkers. Moreover, these studies provide the foundation for further investigation into the pathophysiology of AMD by utilizing a systems-biology-based approach to elucidate underlying mechanistic pathways.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3109/08820538.2011.577129

Cites

237 of 237 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The four SNPs studied have consistently shown the strongest associations with AMD development and progression and have been postulated to influence treatment response.

    “Although other susceptibility genes have been reported, these four SNPs have consistently been shown to have the strongest associations with the development and progression of AMD and have been postulated to influence response to therapy.2,3,12”

    From Pharmacogenetics for Genes Associated with Age-related Macular Degeneration in the Comparison of AMD Treatments Trials (CATT) (2013) · cites this paper as [3]

    The Introduction (page unavailable) identifies the CFH and ARMS2/HTRA1 regions as having large effects on AMD risk, particularly neovascular AMD risk. It does not establish that the four SNPs in the citing study are consistently the strongest for both development and progression. The Conclusions (page unavailable) say that no consistent correlation between genotype and treatment response had been established; they do not support the claim that these four SNPs had been postulated to influence treatment response. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Numerous SNPs in multiple genes have been associated with the prevalence of early and/or late AMD.

    “Pioneering developments in AMD genetics research have identified numerous single nucleotide polymorphisms (SNPs) in multiple genes associated with the prevalence of the early and/or late stages of AMD.2,3”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [227]Gu J Pauer GJ Yue X Narendra U Sturgill GM Bena J Gu X Peachey NS Salomon RG Hagstrom SA Crabb JW The Clinical Genomic and Proteomic AMD Study Group. Proteomic and genomic biomarkers for age-related macular degeneration Adv Exp Med Biol 2010 664 411 417 20238042

Cited by

Sorted by citations

Authors
DeAngelis, M. M., Silveira, A. C., Carr, E. A., & Kim, I. K.
Affiliations
  • Massachusetts Eye and Ear Infirmary (US)
  • University of Utah (US)
Corresponding author
Kim, Ivana K.
Venue
Seminars in Ophthalmology
Published
2011-05
Volume
26
Issue
3
Pages
77-93
ISSN
  • 0882-0538 (ISSN-L)
  • 1744-5205
OpenAlex
W2167667971
Cited by
94
References
237
Citations by year
2026: 2 · 2025: 2 · 2024: 6 · 2023: 5 · 2022: 7 · 2021: 4 · 2020: 5 · 2019: 6 · 2018: 8 · 2017: 1 · 2016: 6 · 2015: 9 · 2014: 6 · 2013: 13 · 2012: 13
FWCI
9.77
Type
journal article
Language
en
Open access
Locations
  • Seminars in Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Eye Institute (P30EY014800)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinal Development and Disorders
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Retinal Imaging and Analysis
Keywords
age-related macular degeneration, genetic susceptibility, genetic susceptibility loci, disease modifiers, biomarkers, pathophysiology, systems biology, genetic association studies
MeSH terms
High-Temperature Requirement A Serine Peptidase 1, Chromosomes, Human, Pair 1, Chromosomes, Human, Pair 10, Humans, Macular Degeneration, Membrane Proteins, Proteins, Serine Endopeptidases, Complement Factor H, Genetic Predisposition to Disease, Intracellular Signaling Peptides and Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review